Chinese Journal of Cancer Prevention & Treatment

Volume 32 Issue 3 (2025): None

Articles

Research progress of CD4+ T cells in malignant tumors; CD4+T细胞在恶性肿瘤中的研究进展

J. Chen,

L. Ye,

J. Li,

S. Zhang,

G. Yang,

P. Li

187-192

Current Status, prognosis and optimized strategies of immunotherapy in elderly patients with non-small cell lung Cancer; 老年非小细胞肺癌免疫治疗现状和预后及优化策略

Y. He,

M. Zhuo

180-186

First-line Tislelizumab therapy in a lung adenocarcinoma patient complicated with hematuria, acute kidney injury and renal metastasis: a case report; 替雷利珠单抗单药一线治疗肺腺癌肾转移并发血尿和急性肾功能不全一例

X. Guo,

Y. Xu,

Y. Wei,

J. Zhao,

X. Gao,

M. Wang

175-179

Establishment of a clinical prediction model for predicting histological Progression of gastric LGIN based on ME-NBI endoscopic morphological parameters; 基于 ME-NBI 内镜形态学参数建立胃 LGIN 组织学进展的临床预测模型

R. Yu,

S. Li,

L. Zhang,

H. Zhao,

L. Er,

X. Zheng

166-174

Effect of Bevacizumab on prognosis after brain radiotherapy in patients with advanced lung adenocarcinoma with EGFR mutation; 贝伐珠单抗对 EGFR 突变晚期肺腺癌脑转移患者脑放疗后预后影响

Y. Zhou,

G. Deng,

Q. Wang,

H. Qin,

J. Li,

Z. Li

158-165

Disease bürden of malignant tumors attributed to dietary risk factors in the population aged 30 and older in China, 1990 — 2021; 1990-2021 年中国 ≥ 30 岁人群归因于饮食危险因素的恶性肿瘤疾病负担研究

D. Zhu,

Z. Zeng,

D. Lu,

S. Chen,

Y. He

151-157

Results and cost-effectiveness of upper gastrointestinal Cancer Screening program in a certain area of Zhejiang Province, 2023; ２０２３年浙江省某地区上消化道癌筛查结果及成本效果分析

J. Deng,

F. Sun,

Y. Fang,

C. Zheng,

B. Huang,

J. Cai

144-150

Clinical TNM Staging assessment and influencing factors analysis of breast Cancer 2021 — 2022 in Henan Province; ２０２１－２０２２年河南省乳腺癌临床犜犖犕分期评估情况及影响因素分析

F. Wang,

X. Chen,

J. Chang,

S. Yang,